Clinical Trials Directory

Trials / Completed

CompletedNCT00885391

QT Variability Pre and Post Cardioversion

QT Variability Pre & Post Cardioversion in Patient's With Atrial Fibrillation

Status
Completed
Phase
Study type
Observational
Enrollment
219 (actual)
Sponsor
Vanderbilt University · Academic / Other
Sex
All
Age
21 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to learn whether the chemicals in the blood and urine are different when the heart is atrial fibrillation compared to normal sinus rhythm.

Detailed description

Atrial Fibrillation variably activates the renin-angiotensin-aldosterone system (RAAS), stimulates the sympathetic nervous system, generates oxidant stress, produces natriuretic peptides, and increases ventricular rate. These are interrelated responses and the extent to which these or other pathophysiologic responses determine QT interval during and after Atrial Fibrillation (AF) is unknown. In this study, the QT variability is related to those potential markers in patients with AF undergoing elective DC-cardioversion.

Conditions

Timeline

Start date
2007-01-01
Primary completion
2012-03-01
Completion
2012-03-01
First posted
2009-04-22
Last updated
2014-12-11

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00885391. Inclusion in this directory is not an endorsement.

QT Variability Pre and Post Cardioversion (NCT00885391) · Clinical Trials Directory